We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Deep Brain Stimulation Benefits Parkinson's Patients

By HospiMedica staff writers
Posted on 08 Oct 2003
A long-term study has found that deep brain stimulation by electrodes implanted on both sides of the brain markedly improves the motor skills of patients with advanced Parkinson's disease. The study was published in the September 2003 issue of the Journal of Neurosurgery.

Researchers followed 25 Parkinson's patients who had electrodes implanted into the region of the subthalamic nucleus on both sides of the brain. The electrodes were wired under the skin to pacemaker-like devices, and the frequency and intensity of stimulation were adjusted. Patients were monitored and evaluated before and after surgery while on and off medication. When patients were off medication, motor skills and the ability to perform daily living activities improved by about 42%. Medication doses were reduced by 38%. The researchers believe the reduction in medication may partly account for the significant decrease in dyskinesia.

"We saw a pronounced decrease in the motor scores associated with Parkinson's disease--the tremors, stiffness, and slowness--and this benefit was persistent through the course of the long-term follow-up,” said Dr. Anthony Lang, professor in the division of neurology at the University of Toronto (Canada), who led the study. Prof. Lang warns that deep brain stimulation, however, will not prevent the disease from worsening, slow its progression, or prevent the development of later problems such as dementia. Still, younger patients like the ones in the study (around 57 years old) did experience sustained improvement for an average of two years after the procedure.




Related Links:
University of Toronto

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Clinical Display
C14S
New
Portable HF X-Ray Machine
PORTX

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization